Cargando…

Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells

Signal transducer and activator of transcription-1 (STAT1) is an important factor in various cellular processes. The cancer stem cell (CSC) is considered as a tumor-initiating cell that drives the inner hierarchy in many cancers including epithelial ovarian cancer (EOC). Here, we explored for the fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fanchen, Zhang, Lingyun, Liu, Jiao, Zhang, Jinguo, Xu, Guoxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346083/ https://www.ncbi.nlm.nih.gov/pubmed/32516753 http://dx.doi.org/10.18632/aging.103317

Ejemplares similares

The Dual Role of STAT1 in Ovarian Cancer: Insight Into Molecular Mechanisms and Application Potentials
por: Li, Xin, et al.
Publicado: (2021)

A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer
por: Zhang, Jinguo, et al.
Publicado: (2021)

Predicting STAT1 as a prognostic marker in patients with solid cancer
por: Zhang, Jinguo, et al.
Publicado: (2020)

RBM15-mediating MDR1 mRNA m(6)A methylation regulated by the TGF-β signaling pathway in paclitaxel-resistant ovarian cancer
por: Yuan, Jia, et al.
Publicado: (2023)

Cyclin dependent kinase 14 as a paclitaxel-resistant marker regulated by the TGF-β signaling pathway in human ovarian cancer
por: Guan, Wencai, et al.
Publicado: (2023)

Predicting Panel of Metabolism and Immune-Related Genes for the Prognosis of Human Ovarian Cancer
por: Zhang, Lingyun, et al.
Publicado: (2021)

Pyridoxine 5′-phosphate oxidase is correlated with human breast invasive ductal carcinoma development
por: Ren, Weimin, et al.
Publicado: (2019)

MALAT1 affects ovarian cancer cell behavior and patient survival
por: Lin, Qunbo, et al.
Publicado: (2018)

Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer
por: Zhang, Lingyun, et al.
Publicado: (2022)

Biological Function of Ribosomal Protein L10 on Cell Behavior in Human Epithelial Ovarian Cancer
por: Shi, Jimin, et al.
Publicado: (2018)

Prognostic value of endoglin-assessed microvessel density in cancer patients: a systematic review and meta-analysis
por: Zhang, Jinguo, et al.
Publicado: (2017)

Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma
por: Chen, Huaizeng, et al.
Publicado: (2019)

Garcinol Alone and in Combination With Cisplatin Affect Cellular Behavior and PI3K/AKT Protein Phosphorylation in Human Ovarian Cancer Cells
por: Zhang, Jie, et al.
Publicado: (2020)

The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer
por: Zhang, Xu, et al.
Publicado: (2018)

Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance
por: Borghese, Cinzia, et al.
Publicado: (2020)

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties
por: HAN, XIAOFENG, et al.
Publicado: (2013)

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties
por: Han, Xiaofeng, et al.
Publicado: (2022)

Lipid-coated albumin-paclitaxel nanoparticles loaded with sorcin-siRNA reverse cancer chemoresistance via restoring intracellular calcium ion homeostasis
por: Wang, Chenglong, et al.
Publicado: (2022)

Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer
por: Tian, Xiaoling, et al.
Publicado: (2018)

Selective cyclooxygenase inhibitors increase paclitaxel sensitivity in taxane-resistant ovarian cancer by suppressing P-glycoprotein expression
por: Lee, Jung-Pil, et al.
Publicado: (2013)

hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance
por: Wadi, Suzan, et al.
Publicado: (2016)

LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
por: An, Jihong, et al.
Publicado: (2017)

Wnt/β-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties
por: Jiménez-Guerrero, Rocío, et al.
Publicado: (2021)

Effect of Starvation in Reversing Cancer Chemoresistance Based on Drug-Resistance Detection by Dextran Nanoparticles
por: Wang, Chenglong, et al.
Publicado: (2020)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer
por: Park, Sun-Ae, et al.
Publicado: (2022)

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway
por: Jinawath, Natini, et al.
Publicado: (2009)

MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells
por: Koh, Hyebin, et al.
Publicado: (2017)

Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
por: Sherman-Baust, Cheryl A, et al.
Publicado: (2011)

Dual Effects of N,N-dimethylformamide on Cell Proliferation and Apoptosis in Breast Cancer
por: Zhang, Jihong, et al.
Publicado: (2017)

CRM197 reverses paclitaxel resistance by inhibiting the NAC‐1/Gadd45 pathway in paclitaxel‐resistant ovarian cancer cells
por: Tang, Xiao‐han, et al.
Publicado: (2019)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
por: Affatato, Roberta, et al.
Publicado: (2022)

Data on the association of CMPK1 with clinicopathological features and biological effect in human epithelial ovarian cancer
por: Zhou, Daibing, et al.
Publicado: (2017)

Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer
por: Wang, Taiwei, et al.
Publicado: (2022)

MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016)

MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
por: Fan, Z, et al.
Publicado: (2016)

circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252
por: Zhang, Shu, et al.
Publicado: (2019)

Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer
por: Zhang, Lingyun, et al.
Publicado: (2017)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
por: Craveiro, Vinicius, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gh0n1rrucih97sprq420e96vrp